Wayne Nursing And Rehabilitation Center Medicare and Medicaid Location: 6999 Route 152, Wayne, West Virginia 25570 Ratings: Phone: (304) 697-7007 |
News Archive
Lilly USA and the National Committee for Quality Assurance have collaborated to release a free online guide and resource library for health care organizations that wish to undertake quality improvement initiatives to improve culturally and linguistically appropriate services and reduce disparities in care.
Amid concerns about the rising number of new tuberculosis cases worldwide, researchers led by Rockefeller University's Seth A. Darst have reexamined and disproved a theory that describes how a potent class of antibiotics kills a deadly form of bacteria. The findings, which will appear in this week's online issue of the Proceedings of the National Academy of Sciences, not only bring scientists closer to understanding how these antibiotics work but also how the bacteria become resistant to their effects.
A new analysis has found that a combination of methods that help patients with dementia remember proper eating habits can improve their physical health and lessen symptoms of depression. Published early online in the Journal of Advanced Nursing, the study indicates that clinicians should consider using this intervention in individuals with dementia who also have poor nutrition and signs of depression.
There is a widespread misunderstanding that stance and gait are automatic processes, i.e. not controlled by the human brain. However, the fact that many patients with brain disorders are no longer able to walk and engage in simple conversation at the same time makes it abundantly clear that our consciousness and our thinking do indeed control such apparently simple actions.
Lixte Biotechnology Holdings announced today that the National Cancer Institute Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), signed a NExT Material Transfer Agreement formalizing a collaboration with Lixte Biotechnology Holdings, Inc. for clinical evaluation of LB-100, one of Lixte's lead anti-cancer compounds.
› Verified 6 days ago